Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07020546

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–47 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Generation Next Fertility

New York, 10022, United States

Location status: Recruiting

Location contact

Alicia L Broussard, PhD

CONTACT

[email protected]

212-641-0906

About this study

. oPRP Treatment & Second IVF Cycle (Study Cycle)

  • Following the first IVF cycle, patients will undergo their first oPRP injection:
  • Timing: 1-2 weeks after the onset of the next menstrual cycle.
  • Procedure: Under IV sedation, a patient's autologous PRP will be prepared and injected directly into both ovaries under transvaginal ultrasound guidance.
  • Second IVF Cycle (oPRP Study Cycle)
  • The same ovarian stimulation protocol will be used for consistency.
  • A second oPRP injection will be performed on stimulation days 2-5 to enhance folliculogenesis.
  • Ovulation will be triggered at the same follicular size thresholds, and oocyte retrieval will follow identical protocols.
  • Fertilization methodology will be identical to the first cycle unless no fertilization is identified in the first cycle.
  • Embryo Development Analysis: Up to 15 embryos will be cultured in the AI incubator, where time-lapse imaging will track their morphokinetics, and AI-based analysis will assess embryo viability and implantation potential.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • No none contraindications to IVF or PRP treatment
  • Adequate ovarian reserves and AMH level
  • Willingness to undergo two IVF cycles and oPRP treatment

Exclusion criteria

  • Anovulation due to menopause or perimenopause
  • Any health conditions that are contraindicated for IVF or oPRP treatment

Treatment and study plan

Ovarian Platelet-rich plasma (PRP) injections

Procedure

This is a procedure that our patients receive at our clinic. We want to use the AI software to evaluate embryo development before and after treatment to see if there is a difference in embryo quality after PRP treatment within the same patient.

Primary outcomes

  1. Blastocyst formation and embryo quality

    Time frame: 1 year

    The number of high quality embryos that are created per cycle

Secondary outcomes

  1. Live birth rate per transfer

    Time frame: 2 years

    The number of live births following embryo transfer

Study contacts

Contact information is provided by the study sponsor or research team.

Alicia L Broussard, PhD

CONTACT

[email protected]

3174456958

Jesse Hade, MD

CONTACT

[email protected]

2126410906

Sponsors and collaborators

Lead sponsor

Generation Next Fertility

Other

Registry information

Official study title

Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 13, 2025
Registry last updated
Jul 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.